CoronaryRadial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials
Under an Elsevier user license
open archive
Key Words
bleeding
femoral access
percutaneous coronary intervention
radial access
vascular complications
Abbreviations and Acronyms
ACS
acute coronary syndrome(s)
CI
confidence interval
MACE
major adverse cardiovascular event(s)
NACE
net adverse clinical event(s)
NSTE
non–ST-segment elevation
NNTB
number of patients needed to treat for an additional beneficial outcome
OR
odds ratio
PCI
percutaneous coronary intervention
STEMI
ST-segment elevation myocardial infarction
Cited by (0)
Dr. Jüni has received research grants to the institution from AstraZeneca, Biotronik, Biosensors International, Eli Lilly, and The Medicines Company; and serves as an unpaid member of the steering groups of trials funded by AstraZeneca, Biotronik, Biosensors International, St. Jude Medical, and The Medicines Company. Dr. Valgimigli has received institutional grants from The Medicines Company and Terumo for the MATRIX trial. All other authors have reported they have no relationships relevant to the contents of this paper to disclose.
© 2016 by the American College of Cardiology Foundation. Published by Elsevier